These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody treatment of human allograft recipients. Delmonico FL; Cosimi AB Surg Gynecol Obstet; 1988 Jan; 166(1):89-98. PubMed ID: 3276014 [TBL] [Abstract][Full Text] [Related]
6. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process. Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207 [No Abstract] [Full Text] [Related]
7. Therapy with monoclonal antibodies to CD4: potential not appreciated? Hall BM Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):71-7. PubMed ID: 2573271 [TBL] [Abstract][Full Text] [Related]
8. Factors affecting therapeutic effect of anti-CD3 and CD4 monoclonal antibody in acute renal allograft rejection. Wang XH; Xie T Transplant Proc; 1996 Jun; 28(3):1306-8. PubMed ID: 8658671 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761 [TBL] [Abstract][Full Text] [Related]
10. Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. Pulito VL; Roberts VA; Adair JR; Rothermel AL; Collins AM; Varga SS; Martocello C; Bodmer M; Jolliffe LK; Zivin RA J Immunol; 1996 Apr; 156(8):2840-50. PubMed ID: 8609403 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687 [TBL] [Abstract][Full Text] [Related]
12. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. Mourad GJ; Preffer FI; Wee SL; Powelson JA; Kawai T; Delmonico FL; Knowles RW; Cosimi AB; Colvin RB Transplantation; 1998 Mar; 65(5):632-41. PubMed ID: 9521196 [TBL] [Abstract][Full Text] [Related]
13. New immunosuppressive therapies in renal transplantation: monoclonal antibodies. Buhaescu I; Segall L; Goldsmith D; Covic A J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678 [TBL] [Abstract][Full Text] [Related]
14. Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection. Wang XH; Xie T Chin Med J (Engl); 1993 Nov; 106(11):821-4. PubMed ID: 8143493 [TBL] [Abstract][Full Text] [Related]
15. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons. Boulday G; Ashton-Chess J; Bernard P; Karam G; Vié H; Moreau A; Minault D; Lorré K; Soulillou JP; Blancho G Nephrol Dial Transplant; 2004 Jul; 19(7):1752-60. PubMed ID: 15069178 [TBL] [Abstract][Full Text] [Related]
16. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Chen Z; Cobbold S; Metcalfe S; Waldmann H Eur J Immunol; 1992 Mar; 22(3):805-10. PubMed ID: 1547823 [TBL] [Abstract][Full Text] [Related]
17. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group. Transplantation; 1997 May; 63(9):1243-51. PubMed ID: 9158016 [TBL] [Abstract][Full Text] [Related]
18. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
19. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596 [TBL] [Abstract][Full Text] [Related]
20. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study. Transplantation; 1997 Apr; 63(8):1087-95. PubMed ID: 9133469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]